Gilead Sciences Inc (NASDAQ:GILD, ETR:GIS)’s twice-yearly injectable HIV prevention drug lenacapavir is on track for a solid launch after being...
Gilead Sciences Inc (NASDAQ:GILD, ETR:GIS)’s twice-yearly injectable HIV prevention drug...
Imugene Limited (ASX:IMU, OTC:IUGNF) (ASX:IMU) (OTCMKTS:IUGNF) is well-funded and ready to...
Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF) CEO Dr Eric Leire talked with Proactive's Stephen Gunnion about multiple recent developments across the company's programs. He highlighted a new manufacturing agreement with CER Groupe, which strengthens Genflow's gene therapy manufacturing...
